http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Intellectual Property and Innovation Issues
Reviews expedited marketing approval, intellectual property, and innovation issues pertaining to follow-on biologics, also called biopharmaceuticals or biotechnology drugs.
Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Dec. 2010). Reuse except for individual research requires license from ProQuest, LLC.
Library of Congress. Congressional Research Service.